Back to List View Graph View

Amylase

Amylase is a group of glycoside hydrolase enzymes that catalyze the digestion of starch and glycogen by cleaving internal α-1,4-glycosidic bonds.

Where the papers sit

10 papers from the last 6 months study amylase directly · updated from PubMed 4 Nov 2026

Study type 0 clinical trials · 3 human data · 7 preclinical

Themes 3 themes · 1 new direction

  • Dual Enzyme Inhibitors in Diabetes

    Synthetic dual inhibitors of α-amylase and α-glucosidase are being developed as alternatives to acarbose for type 2 diabetes. Bis-oxadiazoles, thiazolidinone-thiazoles, benzothiazole conjugates and thiazolidinediones recur across structure-activity, docking and DFT analyses. Reported priorities are improved inhibitory potency, multitarget activity and drug-like ADME properties. Most evidence remains computational or enzymatic, leaving cellular and clinical efficacy unresolved.

    5 papers · 50%

  • Amylase Inhibition and Detection

    Amylase and glucosidase research here combines rapid enzyme detection with phytochemical inhibition of carbohydrate digestion. Interfacial nanozymes are being developed for sensitive amylase quantification, while polysaccharides and plant-derived compounds are tested against α-amylase and α-glucosidase. The biological rationale is improved glucose tolerance and reduced hyperglycemia, supported by biochemical assays and computational binding studies. Evidence remains preclinical, with no clear consensus on which inhibitor class is most effective.

    4 papers · 40%

  • Glycosidase Targeting in Breast Cancer

    Targeted inhibition of α- and β-glucosidase and amylase is being explored as a way to induce metabolic dysfunction in breast cancer cells. The evidence centers on carbohydrate-enzyme inhibition and cell-viability assays rather than clinical outcomes. Acarbose and aminoglycoside or aminocyclitol compounds frame the pharmacological comparisons. Whether this metabolic vulnerability produces selective antitumour activity remains open.

    1 papers · 10%

NEW DIRECTION

Amylase becomes a manufacturing analyte rather than a therapeutic enzyme target

The Au@MOF-235 self-cascading nanozyme for food-manufacturing amylase detection treats amylase as an activity to be quantified, rather than as a carbohydrate-hydrolyzing enzyme to inhibit for diabetes or cancer-related applications. The platform detects α-, β-, γ-amylase, and pullulanase across useful activity ranges with low detection limits, shifting amylase research toward process monitoring and analytical quality control in complex manufacturing environments 42900251Oct.

Papers

The 10 papers from the last 6 months that study amylase directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Dual Enzyme Inhibitors in Diabetes (5)
  1. Computer-aided development of novel thiazolidinone-thiazole derivatives: multidimensional structure-activity relationships revealed by quantum chemical analysis, molecular docking and biological investigation. Journal of computer-aided molecular design · 16 Oct 2026 PMID 42886389
  2. Design, synthesis, and computational assessment of bis-oxadiazole ligands targeting α-amylase and α-glucosidase: DFT, docking, and ADME studies. Future medicinal chemistry · 18 Sept 2026 PMID 42755370
  3. Design, synthesis and biological evaluation of hydroxybenzothiazole-linked benzothiazole/benzoxazole conjugates as potent dual α-amylase and α-glucosidase inhibitors. Bioorganic chemistry · 30 Aug 2026 PMID 42669271
  4. 2,4-thiazolidinediones as dual-target inhibitors against carbohydrate metabolism enzymes in type 2 diabetes. Bioorganic chemistry · 12 Jun 2026 PMID 42284877
  5. β-Maltose-conjugated acetophenone thiosemicarbazones as multitarget inhibitors of diabetes- and Alzheimer's disease-related enzymes: Design, synthesis, and mechanistic evaluation. Bioorganic chemistry · 25 May 2026 PMID 42184581
Amylase Inhibition and Detection (4)
  1. Interfacial engineering-tailored self-cascading nanozyme for sensitive and rapid detection of different amylases. Mikrochimica acta · 20 Oct 2026 PMID 42900251
  2. In silico inhibition mechanism of α-amylase and α-glucosidase by fragransinic acid and bellericagenin B, two compounds from Combretum fragrans F. Hoffm (Combretaceae). Zeitschrift fur Naturforschung. C, Journal of biosciences · 4 Sept 2026 PMID 42696156
  3. Nyctanthes arbor-tristis attenuates hyperglycemia: an integrated experimental and computational investigation. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 27 Aug 2026 PMID 42658420
  4. Structural elucidation and α-amylase/α-glucosidase inhibition properties of xyloglucan and RG-I types polysaccharides from tamarind (Tamarindus indica L.) pulp. Carbohydrate polymers · 23 Jul 2026 PMID 42493157
Glycosidase Targeting in Breast Cancer (1)
  1. Inducing Metabolic Dysfunction in Breast Cancer Cells Through Targeted Inhibition of α- and β-Glucosidase and Amylase: Novel Carbohydrate (C8N) Isomers Designed via Intramolecular aza-Michael-Type Reaction. ChemMedChem · 15 Aug 2026 PMID 42603779

By study type

Human data, design not indexed (3)
  1. Computer-aided development of novel thiazolidinone-thiazole derivatives: multidimensional structure-activity relationships revealed by quantum chemical analysis, molecular docking and biological investigation. Journal of computer-aided molecular design · 16 Oct 2026 PMID 42886389
  2. Design, synthesis, and computational assessment of bis-oxadiazole ligands targeting α-amylase and α-glucosidase: DFT, docking, and ADME studies. Future medicinal chemistry · 18 Sept 2026 PMID 42755370
  3. β-Maltose-conjugated acetophenone thiosemicarbazones as multitarget inhibitors of diabetes- and Alzheimer's disease-related enzymes: Design, synthesis, and mechanistic evaluation. Bioorganic chemistry · 25 May 2026 PMID 42184581
Preclinical: animal, cell and lab studies (7)
  1. Interfacial engineering-tailored self-cascading nanozyme for sensitive and rapid detection of different amylases. Mikrochimica acta · 20 Oct 2026 PMID 42900251
  2. In silico inhibition mechanism of α-amylase and α-glucosidase by fragransinic acid and bellericagenin B, two compounds from Combretum fragrans F. Hoffm (Combretaceae). Zeitschrift fur Naturforschung. C, Journal of biosciences · 4 Sept 2026 PMID 42696156
  3. Design, synthesis and biological evaluation of hydroxybenzothiazole-linked benzothiazole/benzoxazole conjugates as potent dual α-amylase and α-glucosidase inhibitors. Bioorganic chemistry · 30 Aug 2026 PMID 42669271
  4. Nyctanthes arbor-tristis attenuates hyperglycemia: an integrated experimental and computational investigation. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 27 Aug 2026 PMID 42658420
  5. Inducing Metabolic Dysfunction in Breast Cancer Cells Through Targeted Inhibition of α- and β-Glucosidase and Amylase: Novel Carbohydrate (C8N) Isomers Designed via Intramolecular aza-Michael-Type Reaction. ChemMedChem · 15 Aug 2026 PMID 42603779
  6. Structural elucidation and α-amylase/α-glucosidase inhibition properties of xyloglucan and RG-I types polysaccharides from tamarind (Tamarindus indica L.) pulp. Carbohydrate polymers · 23 Jul 2026 PMID 42493157
  7. 2,4-thiazolidinediones as dual-target inhibitors against carbohydrate metabolism enzymes in type 2 diabetes. Bioorganic chemistry · 12 Jun 2026 PMID 42284877